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This work reports the design and evaluation of a rapid loop-mediated isothermal amplification test for detectingMycobacterium
ulceransDNA based on the multicopy insertion sequence IS2404. The test is robust and specific with a detection limit equivalent
to 20 copies of the target sequence (0.01 to 0.1 genome). The test has potential for the diagnosis of Buruli ulcer under field
conditions.
Buruli ulcer (BU) is a destructive disease of the skin and subcu-tis caused by the toxin-producing human pathogenMycobac-
terium ulcerans. Infection often leads to extensive destruction of
skin and soft tissue with associated long-term functional disabil-
ity. The disease has been reported in tropical and subtropical re-
gions of Africa, the Americas, Asia, and the western Pacific. In
poor regions of endemicity of sub-Saharan Africa, the burden of
disease is greatest in children under 15 years (2), and in some
regions, the disease is more common than tuberculosis and lep-
rosy (4). The precise mode of BU transmission remains unclear;
however, research suggests that mosquitoes and some aquatic in-
sects may be either reservoirs or vectors (8, 11). Moreover, activ-
ities such as farming near rivers (12), swimming in rivers/marshes
(1), and dam construction (10) have been associated with in-
creased risk of BU. The occurrence of the disease in poor rural
communities coupled with the lack of simple definitive diagnostic
tests has largely limited the collection of accurate epidemiological
data.
The incidence of M. ulcerans infection has been increasing
while antibiotic treatment regimens and vaccine strategies are still
under investigation. The control of BUpartly depends on accurate
detection of the bacteria in lesions, followed by appropriate treat-
ment of the patient. This has become increasingly important with
clear evidence of the benefit of antibiotic treatment (16). The
common confirmatory methods include direct detection of acid-
fast bacilli (AFB) by smearmicroscopy, culture ofM. ulcerans, and
histopathology (21). However, these methods have limitations in
that they (i) are not readily available in areas of endemicity, (ii)
have low sensitivities, and (iii) have long turnaround times in the
case of culture. To improve methods of confirmation ofM. ulcer-
ans, several PCR formats, all targeting the multicopy insertion
sequence IS2404, have been developed and evaluated, i.e., classical
PCR (18), dry reagent-based (DRB) PCR (19), and TaqMan real-
time PCR (7). Despite these advances in PCR technologies, early
detection of BU remains unsatisfactory in areas of endemicity due
to limited facilities and expertise at health care centers; therefore,
laboratory diagnosis is usually performed retrospectively at major
research centers. Since the best treatment outcome is achieved
when the disease is diagnosed early, a test that permits pretreat-
ment diagnosis in primary health care settings would be of benefit.
In recent years, a rapid and sensitive amplification platform for
DNA called loop-mediated isothermal amplification (LAMP) has
been developed (15). The LAMP technology amplifies DNA with
high sensitivity under isothermal conditions by relying on an en-
zyme with strand displacement activity. Also, the technology uses
4 to 6 specially designed primers recognizing 6 to 8 regions of the
target DNA sequence and hence has a high specificity. The auto-
cycling reactions lead to accumulation of large amounts of the
target DNA and other reaction by-products such as magnesium
pyrophosphate which allow rapid detection using varied formats
(14). The technique has been used widely in laboratory settings to
detect pathogens of medical and veterinary importance and plant
parasitic diseases (6). The platform is robust and specific and
shows tolerance to several biological products that inhibit conven-
tional PCR, meaning that extraction of highly purified DNA tem-
plates may not be necessary. LAMP tests are rapid (1 h) with
sensitivity higher than or equal to that of PCR targeting the same
gene. Amplification can be achieved using a simple incubator such
as a water bath or heating block. In addition, the results can be
visually inspected through a color change or use of a chromato-
graphic lateral flowdipstick format (17). LAMPhas proved a pow-
erful tool in detection of parasite DNA and is cheaper than other
DNA-based tests (20). In this current study, we report the devel-
opment of a rapid and sensitive LAMP test forM. ulcerans target-
ing the repetitive insertion sequence element IS2404.
The institutional ethical clearance for the collection of human
samples in Ghana was approved by the Noguchi Memorial Insti-
tute of Medical Research (NMIMR) Institutional Review Board.
In Australia, DNA extracts from human samples submitted for
routine PCR diagnosis of BU and stored for reference purposes
were deidentified prior to LAMP testing. DNA extracted from the
M. ulcerans reference strain Agy99was used in the development of
the BU LAMP test. A total of 136 and 79 DNA extracts from
Australia and Ghana, respectively, which had been prepared from
swabs, fresh tissue biopsy specimens, and formalin-fixed, paraf-
Received 22 November 2011 Returned for modification 2 January 2012
Accepted 13 February 2012
Published ahead of print 22 February 2012
Address correspondence to Zablon K. Njiru, z.njiru@uq.edu.au.
Copyright © 2012, American Society for Microbiology. All Rights Reserved.
doi:10.1128/JCM.06460-11










fin-embedded tissue and previously analyzed with TaqMan real-
time PCR or standard PCR (18), were used for the validation.
Further, nine cultured isolates were used. DNA extracts from a
series of soil, water, algal, and possum fecal samples spiked with
M. ulcerans and prepared as part of a WHO-sponsored quality
assurance program (QAP) for the PCR detection ofM. ulcerans in
environmental samples were also included in the analysis. The
DNA from the clinical and environmental samples was extracted
as previously described (7). In addition, twoM. ulcerans-positive
tissue specimens from Australia were randomly selected and heat
treated. Briefly, the tissues were macerated and homogenized in a
bottle containing glass beads and phosphate-buffered saline. Ap-
proximately 0.5 ml of the homogenate was incubated at 95°C in a
heating block for 30 min, followed by centrifugation at 14,000
rpm for 5min. The resulting supernatant was used in the analysis.
Three sets of LAMP primers consisting of six primers for each
set were designed targeting the ketoreductase B domain (KR-B)
and IS2404 (accession no. BX649209), respectively, and using
the software Primerexplorer. The primer specificity was checked
using the basic local alignment search tool (BLAST) against hu-
man DNA and other mycobacterial sequences in the nonredun-
dant GenBank database, after which the performance of the
primer sets was tested using the standard LAMP conditions for
“must-detect samples,” i.e.,M. ulceransDNA from varied spec-
imens, and “must-not-detect samples,” i.e.,Mycobacterium in-
tracellulare, Mycobacterium leprae, Mycobacterium chelonae,
Mycobacterium lepraemurium, Mycobacterium avium, and My-
cobacterium marinum. The set(s) of primers that passed these
criteria was then analyzed using a 10-fold serial dilution set of
DNA from M. ulcerans Agy99, followed by the selection of the
set that was most sensitive (Fig. 1).
The 25-l LAMP reaction mixtures were standardized for op-
timal temperature and time using M. ulcerans Agy99 DNA, ac-
cording to the Taguchi method (3) and as previously described
(17). The template used for optimization was 100 pg of DNA,
and the reactions were carried out for 1 h at 62°C using the Rotor-
Gene 6000 (Qiagen Inc., Valencia, CA) and terminated by increas-
ing the temperature to 80°C for 4 min. Three methods were used
to detect the BU LAMP product, namely, (i) electrophoresis
through 2.0% agarose gels stained with SYBR Safe DNA gel stain
(Invitrogen, Carlsbad, CA), (ii) visual inspection after addition of
a 1:10 dilution of SYBR green I, and (iii) monitoring the fluores-
cence of double-stranded DNA (dsDNA) using the Rotor-Gene
6000. The real-time fluorescence data were obtained on the 6-car-
boxyfluorescein (FAM) channel (excitation at 470 nm and detec-
tion at 510 nm). Confirmation of the BULAMPproduct was done
through HhaI restriction enzyme digestion followed by electro-
phoresis in a 3% agarose gel and postamplification acquisition of
melting curves on the FAMchannel using 1°C steps, with a hold of
30 s, from 63°C to 96°C (13). A serial 10-fold dilution ofM. ulcer-
ans strain Agy99 DNA (480 ng/l) was used to determine the
analytical sensitivity of the assay, and results were compared with
those of TaqMan real-time PCR testing and classical PCR. Addi-
tional assay specificity was determined using DNA extracted from
clinical specimens from skin lesions previously shown to contain
M. intracellulare,M. leprae,M. chelonae,M. lepraemurium, andM.
avium.
The Taguchi method determined the optimal concentration
for forward and backward inner primers (FIP and BIP, respec-
tively) at 40 pmol, 2 mM for each deoxynucleotide triphosphate,
1.2 M betaine, and 3 mM extra magnesium sulfate. Concentra-
tions of other reagents were as previously reported (17). The BU
FIG 1 The partial nucleotide sequence of amulticopy insertion sequence, IS2404, showing themost sensitive LAMPprimer set. The restriction enzymeHhaI site
is shown as a red line. The primers are as follows: F3, forward; B3, backward; LF, loop forward; LB, loop backward; FIP, forward inner (F1c and F2); BIP, backward
inner (B2c and B1c).
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LAMP optimum temperature was determined to be 62°C, and the
reaction cutoff time was determined to be 35 min. The optimized
LAMP conditions were more efficient, showing a reduction in
reaction time of 6 min per every 10-fold serial dilution com-
pared with the standard LAMP conditions using a real-time PCR
machine. The analytical sensitivities of the classical PCR and Taq-
Man real-time PCR assays as determined through 10-fold serial
dilution were 106 (2,000 copies) and 109 (2 copies), respec-
tively, while those of the KR-B- and IS2404-based LAMP tests
were 105 and 108 (20 copies), respectively. As such, the KR-B
test was not further developed. The IS2404 LAMP assay was spe-
cific, and no cross-reactivity was recorded with nontarget DNA of
closely related Mycobacterium spp. Positive LAMP reactions
showed exponential amplification curves (similar to those in Fig.
2B) with cycle threshold values (CT) ranging from 15 to 32 for the
M. ulcerans-positive clinical samples tested. Electrophoresis of the
same product on a 2.0% agarose gel showed a ladder-like pattern,
indicating the formation of stem-loops with inverted repeats. On
addition of 1 l of a 1:10 dilution of SYBR green I to the same
samples, all the positive samples turned green while the negatives
remained brown/orange (Fig. 2A). The acquired melting curves
showed melting temperatures (Tm) of 89°C, while the restric-
tion enzyme digestion indicated the predicted products of87 bp
and 126 bp. In the analysis of primary specimens, the tests were
performed in duplicate, and in cases of discrepancies, the test in
question was repeated a third time, the results of which were con-
sidered final. Agreement between the tests was determined using
the kappa index estimated at the 95% confidence interval (95%
CI). The developed assay was further tested in an isothermal am-
plification and detection unit (ESE-Quant tube scanner; ESE
GmbH., Stockach, Germany), which was set to collect fluores-
cence signals at 1-min intervals. The ESE-Quant tube scanner pro-
vides a major advancement toward “electricity-free” technology
for LAMP technology and offers a single-step amplification and
product detection step. The device is simple to operate, small (74
mm high by 178 mm wide by 188 mm), and lightweight (1 kg).
The IS2404 LAMP test was able to detect seven M. ulcerans
DNAs in the environmental QAP samples (Table 1) and directly
from the supernatant derived from two heat-treated tissue speci-
mens (Fig. 2A). Results for the DNA extracts from primary spec-
imens fromAustralia showed a kappa value of 0.8 (95%CI, 0.70 to
0.98) between TaqMan real-time PCR and LAMP, and those from
Ghana showed a kappa value of 0.7 (95%CI, 0.60 to 0.89) between
PCR and LAMP, respectively (Table 1). The ESE-Quant tube
scanner showed results identical to those of the Rotor-Gene 6000,
with the amplification of M. ulcerans DNA showing sigmoid
curveswhile the negative controls had nomeasurable fluorescence
as indicated by flat lines in the plot (Fig. 2B).
The LAMP technology in its simplest form offers the potential
for on-site testing for a pathogen, as an alternative to methodolo-
FIG 2 (A) The visual appearance of the BU LAMP amplification product after addition of a 1:10 dilution of SYBR green I dye. The dye fluoresces strongly when
bound to the double-stranded DNA, and the resulting DNA-dye complex gives a green color, while fluorescence is minimal when the dye is free in the solution
and gives an orange/brown color. (B) The amplification curves obtained using the ESE-Quant tube scanner. Results can be read using the LCD panel as either
positive or negative and/or in real time using a computer with the appropriate software (9). The graph reports the fluorescence in millivolts (mV) on the y axis
and time inminutes on the x axis. Sample 1,M. ulcerans-spiked soil; 2, supernatant frompositive specimen; 3, DNA fromneedle aspirate; 4,M.marinum; control
(C),M. ulcerans DNA (Agy99); negative control (NC), water.
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gies requiring sophisticated instrumentation, present only in spe-
cialized laboratories. The IS2404 BU LAMP designed in this study
has an analytical sensitivity comparable to that of TaqMan real-
time PCR, which is equivalent to 0.01 to 0.1 genome (2 to 20
copies of the target sequence) (7). This is an excellent detection
limit, taking into account the simplicity and the rapidity of the
assay (35 min) compared to other DNA tests. Moreover, the
large amount of dsDNA formed allows visual inspection of results
using varied formats. The potential usefulness of BU LAMP as a
point-of-care test is further demonstrated by the ability of the new
assay to amplify target DNA from supernatant prepared from
heat-treated specimens (tissue), meaning that DNA extraction
may not be necessary. We recorded no inhibition of LAMP reac-
tions or formation of nonspecific products with the use of up to 3
l of supernatant from heat-treated samples. The possibility of
heating the specimens directly to obtain template shortens the
overall assay time; however, this method requires rigorous evalu-
ation. The BU LAMP assay reported here has a clear advantage
over most nucleic acid amplification assays in that the test is ro-
bust and simple and requires less instrumentation to make a di-
agnosis.
It is crucial to ensure that any designed LAMP assay amplifies
the target DNA, since most product detection methods do not
offer the chance of confirming the end product; e.g., SYBR green I,
the dye of choice, binds nonspecifically to any dsDNA such as
primer-dimers and spurious amplicons, leading to errors in inter-
pretation, (17). We confirmed that our BU LAMP assay amplifies
the correct product through HhaI restriction enzyme digestion,
which gave the predicted product sizes of87 bp and 126 bp. In
addition, the postamplification acquisition of the melting curves
of products amplified from M. ulcerans from both Ghana and
Australia revealed a consistent Tm of 89°C, indicating similar
sequence compositions. The combination of these results and the
use of three negative controls per test run increases our confidence
when using SYBR green I to detect the BU LAMP product. The
LAMP detection methods are still in their infancy; however, it is
worth noting that higher test specificity can be achieved by target-
ing an internal sequence of the amplicon through incorporating a
fluorescent molecular beacon probe and thus minimizing non-
specific signal (5) or using a lateral flow dipstick format. Although
lateral flowmatrix is slightly more expensive than nonspecific flu-
orescence dyes, it shows improved LAMP test specificity and pres-
ents one way of developing the assay into a field-applicable format
(17), especially when the heat treatmentmethod is used to prepare
the LAMP template. In general, an ideal LAMP detection format
should be specific and include a closed amplification and detec-
tion unit to limit amplicon contamination, an inherent problem
with many assays involving nucleic acid amplification and espe-
cially in less sophisticated settings.
The final components that will constitute a point-of-care test
for BU should be affordable and simple to perform without com-
promising sensitivity and specificity. The ESE-Quant tube scanner
tested here is a major advancement toward this goal because the
device permits single-step amplification and product detection.
The device uses a customized rechargeable battery, and results are
obtained directly using the device liquid crystal display (LCD)
window or software installed on a laptop computer, thus avoiding
post-DNA manipulation (Fig. 2B). Our preliminary data suggest
that the device can reliably be used to detect various pathogens of
medical and veterinary importance (data not shown) with sensi-
tivity identical to that of the Rotor-Gene 6000. Therefore, the ESE-
Quant tube scanner can potentially allow detection of BU in re-
source-poor areas of endemicity. A good performance of the
device has also been reported (9) in detection of malaria parasites.
The downside of the device is that it can accommodate only eight
samples and uses nonspecific dye; therefore, modification is re-
quired to expand the device to accommodate more samples.
The development of the BU LAMP assay in this work, based on
the target that is currently used for the diagnosis of BU, may po-
tentially improve the detection of early disease in the field. Our
results indicate that the LAMP assay was able to detect 83% of
PCR-positive DNA extracts from Australia and Ghana and ini-
tially prepared from varied primary specimens (Table 1). How-
ever, the BU LAMP failed to detect three of the TaqMan PCR-
positive samples and eight PCR-positive samples (Table 1). It is
possible that (i) the pathogen DNA concentration in the three
samples was below the LAMP detection level, as our results indi-
cate that TaqMan PCRwasmore sensitive than BU LAMP, and/or
that (ii) DNA degradationmay have occurred in the eight samples
fromGhana after a long storage period (Table 1). The latter idea is
supported by the repeat of PCR testing using the same aliquot, in
which no positive signals were recorded. Among the samples from
Australia andGhana found to be negative byTaqMan and classical
PCR, respectively, the LAMP test showed positive signals from
two samples in each group. It was not possible to determine
whether the two archived Australian samples were false positives;
however, the two samples from patients in Ghana are being fol-
lowed to ascertain the patients’ disease status, since these are re-
cent cases.
In summary, this study has shown that the BU LAMP has good
sensitivity that is comparable to that of PCR tests (kappa values,
0.7 to 0.8); therefore, the LAMP assay may be used to reliably
detectM.ulceransDNA. It is unlikely that the PCR-basedmethods
TABLE 1 Analysis of various DNA extracts using standard PCR,















8 NDh 8 7
Heat-treated
specimensc
2 2 2 2
Australian clinical
specimensd
136 ND 18 15 (83.3%f) 0.87
Ghanaian clinical
specimense
79 50 ND 42 (84%g) 0.74
a Cultured isolates (7).
b Water, algae, soil, and possum excreta.
c Human tissue.
d Swabs, tissues (fresh biopsy specimens or scrapings and formalin-fixed, paraffin-
embedded tissue), and koala feces (1 sample only).
e Swabs and fine-needle aspirate.
f Percent ratio of LAMP- to TaqMan PCR-positive samples.
g Percent ratio of LAMP- to PCR-positive samples.
h ND, not done.
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will soon be integrated into routine point-of-care diagnosis of BU
disease in areas of endemicity, largely due to the lack of sophisti-
cated laboratories; rather, they will remain invaluable in reference
laboratories. The BU LAMP assay developed here has potential to
contribute toward the early detection of BU and confirmation of
clinically diagnosed cases. Furthermore, the assay may contribute
toward a better understanding of the epidemiology, ecology, and
mode of transmission ofM. ulcerans. Our next step is to lyophilize
theBULAMPassay, develop a dipstick detectionmatrix, and carry
out extensive field evaluations.
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